Key Resources


ASGE Guidelines

ASGE evidence-based guidelines provide clinicians with recommendations for the evaluation, diagnosis, and management of patients undergoing endoscopic procedures of the digestive tract. Guidelines are not a substitute for physicians’ opinion on individual patients. Final decision on an intervention should always be based on local expertise and patient preferences.

All recommendations follow a rigorous process based on a systematic review of medical literature as outlined by the National Academy of Medicine (formerly Institute of Medicine) standards for guideline development.

Whenever possible, guidelines are based on the GRADE (Grading of Recommendation Assessment, Development and Evaluation) methodology.

Panels consist of content experts, stakeholders from other specialties, patient representatives, and members of the ASGE Standards of Practice (SOP) Committee.

Each recommendation is based on consideration of the best medical literature, the balance between risks and benefits, cost-effectiveness, patients’ values, and equity.

Panel members provide ongoing conflict of interest (COI) disclosures, including intellectual conflicts of interest, throughout the development and publication of all guidelines in accordance with the ASGE Policy for Managing Declared Conflicts of Interests.

ASGE strives to provide clinically relevant and practical recommendations, which can help standardize patient care and improve outcomes.

If you have any questions or suggestions, please contact Customer Support at Info@asge.org.

The following information is intended only to provide general information and not as a definitive basis for diagnosis or treatment in any particular case. It is very important that you consult your doctor about your specific condition.

Newly Published

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
GRADE Guidelines

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Upper GI

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Lower GI

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Biliary and Pancreatic Endoscopy

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Adverse Events

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Privileging and Credentialing

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
GI Endoscopy Unit Operations

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Screening and Surveillance in Premalignant Conditions

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Procedural Management in Endoscopy

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Miscellaneous

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059
Guidelines in Spanish

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059

In Progress Guidelines

ASGE Guideline on the Role of Endoscopy in the Management of Malignant Hilar Obstruction

Early 2021

ASGE Guideline on the Management of Cholangitis

Early 2021

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility

Estimated 2021

ASGE Guideline on the Role of Endoscopic Submucosal Dissection in the Management of Esophageal and Gastric Mucosal Neoplasia

Estimated 2021

Quality in Endoscopy

Quality documents define the indicators of high-quality endoscopy and how to measure it. ASGE quality indicators are based on a rigorous review process which results in valid metrics for evaluating GI endoscopic procedures. 

Quality in Endoscopy

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Sep 28, 2017, 14:27 PM
Colorectal cancer (CRC) screening is the process of detecting early-stage CRCs and precancerous lesions in asymptomatic people with no prior history of cancer or precancerous lesions. The U.S. Multi-Society Task Force of Colorectal Cancer (MSTF) is a panel of expert gastroenterologists representing the American College of Gastroenterology, the American Gastroenterological Association, and the American Society for Gastrointestinal Endoscopy. The MSTF, like others, has long endorsed systematic offers of CRC screening to average-risk persons (persons without a high-risk family history of colorectal neoplasia) beginning at age 50 years, with general evidence supporting screening reviewed in previous publications.1 This publication updates the screening recommendations of the MSTF for screening in average-risk persons.
Douglas K. Rex, MD'Correspondence information about the author MD Douglas K. RexEmail the author MD Douglas K. Rex, C. Richard Boland, MD, Jason A. Dominitz, MD, MHS, Francis M. Giardiello, MD, David A. Johnson, MD, Tonya Kaltenbach, MD, Theodore R. Levin, MD, David Lieberman, MD, Douglas J. Robertson, MD, MPH
Title : Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer
Doi org link : http://dx.doi.org/10.1016/j.gie.2017.04.003
Volume : Gastrointest Endosc July 2017 Volume 86, Issue 1, Pages 18–33
URL :
Select a choice : Keep
Content created : Sep 28, 2017, 00:00 AM
File size :
Number :
ExternalPK :

Categories :
  • Colonoscopy
  • Colorectal
  • Lower GI
Tags :
PIIS0016510717318059

Technology Assessments

Technology evaluations provide a review of existing, new, or emerging endoscopic technologies that have an impact on the practice of GI endoscopy. Evaluations are based on a literature review and a search of the MAUDE (U.S. Food and Drug Administration Center for Devices and Radiological Health) database to identify the reported adverse events of a given technology. When financial guidance is indicated, the most recent coding data and list prices at the time of publication are provided.

Technology Assessments
80_logo